VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
IH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
IHiHuman Inc.
$1.00$10M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksIHBalance Sheet

iHuman Inc. (IH) Balance Sheet

8Y historyFree accessUpdated daily

The company maintains a robust liquidity profile with a current ratio of 3.55 and minimal debt, as evidenced by a debt-to-equity ratio of only 0.01.

Income StatementBalance SheetCash FlowRatios

IH Balance Sheet

Annual statement

IH Balance Sheet

iHuman Inc. (IH) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets1.18B1.3B1.34B1.38B1.25B1.02B1.02B163.06M57.33M
Cash & Short-Term Investments1.01B1.15B1.17B1.21B1.05B855.36M861.68M104.88M6.12M
Cash Only796.39M1.15B1.12B1.21B1.05B855.36M861.68M104.88M6.12M
Short-Term Investments211.36M045.46M000000
Accounts Receivable45.23M51.42M54.08M62.64M81.9M58.98M78.29M20.98M13.62M
Days Sales Outstanding26.3123.2521.422.4630.3322.7953.7235.0337.71
Inventory33.38M21.4M23.48M16.52M19.13M28.05M16.87M20.66M29.63M
Days Inventory Outstanding37.4130.1130.3820.3123.7236.043789.62164.22
Other Current Assets93.15M74.53M69.2M72.5M102.77M72.85M64.62M14.09M7.64M
Total Non-Current Assets64.31M70.02M83.82M68.06M79.61M85.64M25.48M5.25M1.27M
Property, Plant & Equipment11.88M14.16M18.36M9.82M21.99M50.52M12.91M2.49M660K
Fixed Asset Turnover55.48x57.00x50.23x103.71x44.82x18.70x41.20x87.92x199.80x
Goodwill000000000
Intangible Assets15.5M17.65M16.43M23.25M24.87M27.29M11.79M103K136K
Long-Term Investments105.27M26.35M26.33M26.33M26.33M0000
Other Non-Current Assets10.59M11.87M22.7M8.66M6.42M7.83M784K2.66M478K
Total Assets1.24B1.37B1.42B1.45B1.33B1.1B1.05B168.31M58.6M
Asset Turnover0.57x0.59x0.65x0.70x0.74x0.86x0.51x1.30x2.25x
Asset Growth %-17.72%-3.55%-2.13%8.78%21.12%5.15%522.02%187.23%-
Total Current Liabilities405.02M364.21M447.54M490.76M561.05M482.93M399.22M182.76M122.33M
Accounts Payable18.58M25.1M30.23M22.14M24.21M30.54M21.55M10.3M13.13M
Days Payables Outstanding35.8835.3239.1227.2230.0239.2347.2544.6872.8
Short-Term Debt1.7M2.17M00000061.82M
Deferred Revenue (Current)889.41M220.05M283.25M318.59M379.06M302.98M268.61M71.83M28.15M
Other Current Liabilities153.16M116.89M5.82M4.91M5.17M7.36M3.34M70.96M29.94M
Current Ratio2.91x3.57x2.98x2.82x2.23x2.10x2.56x0.89x0.47x
Quick Ratio2.83x3.51x2.93x2.78x2.20x2.04x2.52x0.78x0.23x
Cash Conversion Cycle27.8418.0512.6615.5524.0319.643.4679.97129.13
Total Non-Current Liabilities6.63M9.21M11.25M1.93M2.89M9.58M5.07M00
Long-Term Debt000000000
Capital Lease Obligations34.22M9.21M11.25M1.93M2.89M9.58M5.07M00
Deferred Tax Liabilities000000000
Other Non-Current Liabilities000000000
Total Liabilities411.65M373.42M458.8M492.69M563.95M492.51M404.29M182.76M122.33M
Total Debt8.33M11.38M14.91M3.86M9.02M34.25M6.61M061.82M
Net Debt-788.06M-1.14B-1.11B-1.21B-1.04B-821.12M-855.07M-104.88M55.7M
Debt / Equity0.01x0.01x0.02x0.00x0.01x0.06x0.01x--
Debt / EBITDA0.93x0.15x0.17x0.02x0.07x----
Net Debt / EBITDA-87.84x-15.31x-12.95x-7.05x-8.50x----
Interest Coverage---------
Total Equity832.18M995.8M960.85M957.8M769.45M608.37M642.65M-14.45M-63.73M
Equity Growth %-2.82%3.64%0.32%24.48%26.48%-5.33%4547.73%77.33%-
Book Value per Share81.4093.0388.5787.4771.1957.0470.98-1.35-5.98
Total Shareholders' Equity832.18M995.8M960.85M957.8M769.45M608.37M642.65M-14.45M-63.73M
Common Stock186.06K186.12K185K185K185K185K184K158K111K
Retained Earnings-49.3M53.26M-42.1M-140.46M-321.17M-423.02M-385.97M-348.5M-72.9M
Treasury Stock-43.5M-43.51M-26.3M-16.66M-7.12M-164K000
Accumulated OCI14.84M24.61M32.4M26.12M18.46M-34.68M-21.86M0-532K
Minority Interest000000000

Key Metrics

Growth RegimeContracting
ProfitabilityModerate
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Capital deployment and demographic headwinds

Balance Sheet Stability Amid Contraction

As reported in recent financial filings, iHuman maintains a fortress-like balance sheet with total assets of $1.3 billion, yet the persistent decline in retained earnings suggests that the company's core operational trajectory remains challenged by broader market saturation and demographic headwinds in the Chinese education sector.

The company's ability to preserve its asset base despite revenue contraction highlights a conservative financial posture. However, the ongoing erosion of retained earnings indicates that the business model is struggling to generate sufficient organic growth to offset its fixed cost structure.

Excessive Liquidity and Deployment Uncertainty

Based on the latest quarterly data, iHuman holds a substantial cash position of $605.1 million, which, while providing a robust current ratio of 3.55, raises questions regarding management's inability to effectively deploy this capital to reverse the company's current top-line revenue decline.

The high liquidity buffer serves as a significant safety net against regulatory or market shocks, yet it also acts as a drag on return on equity. Investors should monitor whether this cash pile remains idle or if management eventually pivots toward more aggressive capital allocation strategies.

Deferred Revenue Trends Signal Weakness

According to historical balance sheet disclosures, deferred revenue has trended downward to $240.0 million in 2025Q2, which serves as a leading indicator of potential future revenue weakness and suggests that the company's subscription-based model is facing increasing pressure from a shrinking addressable market.

The decline in unearned revenue suggests that new subscription intake is failing to keep pace with the recognition of existing contracts. This trend warrants further investigation into whether the company's edutainment offerings are losing their competitive edge in the domestic Chinese market.

Equity Quality and Retained Earnings

As indicated by the company's financial statements, the shift in retained earnings from a deep deficit of $267.5 million in 2023Q1 to a positive $16.3 million in 2025Q2 reflects a significant accounting turnaround, though this improvement appears largely disconnected from the company's underlying operational growth.

The improvement in equity quality is a positive development, yet it may be influenced by non-operating factors rather than core business expansion. Analysts should remain cautious about the sustainability of this trend given the ongoing revenue contraction and the lack of clear catalysts for future growth.

IH — Frequently Asked Questions

Quick answers to the most common questions about buying IH stock.

What are the total assets of iHuman Inc. (IH)?

As of 2025, iHuman Inc. (IH) had total assets of $1.37B including $1.30B in current assets.

How much debt does iHuman Inc. (IH) have?

iHuman Inc. (IH) carries total debt of $11.4M, offset by $1.15B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of iHuman Inc.?

iHuman Inc. (IH) has total shareholders' equity (book value) of $995.8M ($93.03 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is iHuman Inc.'s current ratio and liquidity?

iHuman Inc. (IH) reported a current ratio of 3.57x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.